AKZA.AS: Akzo Nobel N.V. Financials
Akzo Nobel N.V. Income Statement
Total revenue
Net income
Gross margin TTM
39.86%
Operating margin TTM
7.62%
Net profit margin TTM
6.25%
Return on investment TTM
13.63%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,158,000,000 | 10,711,000,000 | 10,668,000,000 | 10,846,000,000 |
| Operating income | 774,000,000 | 917,000,000 | 1,029,000,000 | 708,000,000 |
| Net income | 635,000,000 | 542,000,000 | 442,000,000 | 352,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,158,000,000 | 10,711,000,000 | 10,668,000,000 | 10,846,000,000 |
| Cost of revenue | 6,109,000,000 | 6,374,000,000 | 6,434,000,000 | 6,923,000,000 |
| Gross profit | 4,049,000,000 | 4,337,000,000 | 4,234,000,000 | 3,923,000,000 |
| Research and development expenses | 0 | 296,000,000 | 270,000,000 | 258,000,000 |
| General and administrative expenses | 3,275,000,000 | 323,000,000 | 328,000,000 | 338,000,000 |
| Selling and marketing expenses | 0 | 1,240,000,000 | 1,210,000,000 | 1,193,000,000 |
| Selling, general and administrative expenses | 3,275,000,000 | 1,563,000,000 | 1,538,000,000 | 1,531,000,000 |
| Other expenses | 0 | 1,561,000,000 | 1,397,000,000 | 1,426,000,000 |
| Operating expenses | 3,275,000,000 | 3,420,000,000 | 3,205,000,000 | 3,215,000,000 |
| Cost and expenses | 9,384,000,000 | 9,794,000,000 | 9,639,000,000 | 10,138,000,000 |
| Net interest income | -199,000,000 | -102,000,000 | -123,000,000 | -77,000,000 |
| Interest income | 0 | 88,000,000 | 69,000,000 | 29,000,000 |
| Interest expense | 199,000,000 | 190,000,000 | 192,000,000 | 106,000,000 |
| Depreciation and amortization | 378,000,000 | 371,000,000 | 355,000,000 | 362,000,000 |
| EBITDA | 1,542,000,000 | 1,399,000,000 | 1,413,000,000 | 1,052,000,000 |
| EBIT | 1,164,000,000 | 1,028,000,000 | 1,056,000,000 | 690,000,000 |
| Non-operating income (excl. interest) | -390,000,000 | -111,000,000 | -27,000,000 | 18,000,000 |
| Operating income | 774,000,000 | 917,000,000 | 1,029,000,000 | 708,000,000 |
| Total other income/expenses (net) | 224,000,000 | -79,000,000 | -245,000,000 | -106,000,000 |
| Income before tax | 998,000,000 | 838,000,000 | 784,000,000 | 602,000,000 |
| Income tax expense | 326,000,000 | 246,000,000 | 296,000,000 | 214,000,000 |
| Net income from continuing operations | 672,000,000 | 592,000,000 | 488,000,000 | 388,000,000 |
| Net income from discontinued operations | -1,000,000 | 0 | -5,000,000 | -10,000,000 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 635,000,000 | 542,000,000 | 442,000,000 | 352,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 635,000,000 | 542,000,000 | 442,000,000 | 352,000,000 |
| EPS | 4 | 3 | 3 | 2 |
| Diluted EPS | 4 | 3 | 3 | 2 |
| Weighted average shares outstanding | 171,000,000 | 170,728,870 | 170,600,000 | 174,735,139 |
| Weighted average diluted shares outstanding | 172,086,721 | 171,518,987 | 171,338,756 | 175,313,498 |
Akzo Nobel N.V. Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
3,476,000,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 13,952,000,000 | 14,249,000,000 | 14,558,000,000 | 14,741,000,000 |
| Total liabilities | 9,130,000,000 | 9,433,000,000 | 10,012,000,000 | 10,193,000,000 |
| Total equity | 4,659,000,000 | 4,574,000,000 | 4,322,000,000 | 4,333,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,618,000,000 | 1,302,000,000 | 1,513,000,000 | 1,450,000,000 |
| Short-term investments | 302,000,000 | 165,000,000 | 265,000,000 | 336,000,000 |
| Cash and short-term investments | 1,920,000,000 | 1,467,000,000 | 1,778,000,000 | 1,786,000,000 |
| Net receivables | 2,612,000,000 | 2,273,000,000 | 2,276,000,000 | 2,215,000,000 |
| Accounts receivable | 2,403,000,000 | 2,144,000,000 | 2,187,000,000 | 2,123,000,000 |
| Other receivables | 209,000,000 | 129,000,000 | 89,000,000 | 92,000,000 |
| Inventory | 1,529,000,000 | 1,721,000,000 | 1,649,000,000 | 1,843,000,000 |
| Prepaid expenses | 35,000,000 | 42,000,000 | 39,000,000 | 58,000,000 |
| Other current assets | -35,000,000 | 333,000,000 | 302,000,000 | 342,000,000 |
| Total current assets | 6,061,000,000 | 5,836,000,000 | 6,044,000,000 | 6,244,000,000 |
| Property, plant and equipment (net) | 2,333,000,000 | 2,440,000,000 | 2,296,000,000 | 2,259,000,000 |
| Goodwill | 1,392,000,000 | 1,443,000,000 | 1,430,000,000 | 1,377,000,000 |
| Intangible assets | 2,406,000,000 | 2,606,000,000 | 2,651,000,000 | 2,695,000,000 |
| Goodwill and intangible assets | 3,798,000,000 | 4,049,000,000 | 4,081,000,000 | 4,072,000,000 |
| Long-term investments | 468,000,000 | 250,000,000 | 44,000,000 | -59,000,000 |
| Tax assets | 792,000,000 | 422,000,000 | 512,000,000 | 498,000,000 |
| Other non-current assets | 500,000,000 | 1,252,000,000 | 1,581,000,000 | 1,727,000,000 |
| Total non-current assets | 7,891,000,000 | 8,413,000,000 | 8,514,000,000 | 8,497,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 13,952,000,000 | 14,249,000,000 | 14,558,000,000 | 14,741,000,000 |
| Total payables | 2,829,000,000 | 2,844,000,000 | 2,523,000,000 | 2,442,000,000 |
| Accounts payable | 2,690,000,000 | 2,740,000,000 | 2,312,000,000 | 2,206,000,000 |
| Other payables | 139,000,000 | 104,000,000 | 211,000,000 | 236,000,000 |
| Accrued expenses | 0 | 0 | 598,000,000 | 516,000,000 |
| Short-term debt | 1,112,000,000 | 1,606,000,000 | 2,309,000,000 | 2,457,000,000 |
| Capital lease obligations (current) | 80,000,000 | 91,000,000 | 89,000,000 | 86,000,000 |
| Tax payables | 0 | 120,000,000 | 211,000,000 | 420,000,000 |
| Deferred revenue | 0 | 0 | 10,000,000 | 0 |
| Other current liabilities | 186,000,000 | 189,000,000 | 177,000,000 | 245,000,000 |
| Total current liabilities | 4,207,000,000 | 4,730,000,000 | 5,706,000,000 | 5,746,000,000 |
| Long-term debt | 3,476,000,000 | 3,470,000,000 | 2,971,000,000 | 3,134,000,000 |
| Capital lease obligations (non-current) | 194,000,000 | 201,000,000 | 194,000,000 | 198,000,000 |
| Deferred revenue (non-current) | 0 | 0 | 194,000,000 | 0 |
| Deferred tax liabilities (non-current) | 487,000,000 | 491,000,000 | 557,000,000 | 561,000,000 |
| Other non-current liabilities | 766,000,000 | 541,000,000 | 390,000,000 | 554,000,000 |
| Total non-current liabilities | 4,923,000,000 | 4,703,000,000 | 4,306,000,000 | 4,447,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 274,000,000 | 292,000,000 | 283,000,000 | 284,000,000 |
| Total liabilities | 9,130,000,000 | 9,433,000,000 | 10,012,000,000 | 10,193,000,000 |
| Treasury stock | 0 | 0 | 0 | 0 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 86,000,000 | 85,000,000 | 85,000,000 | 87,000,000 |
| Retained earnings | 5,374,000,000 | 5,068,000,000 | 679,000,000 | 4,936,000,000 |
| Additional paid-in capital | 0 | 0 | 0 | 0 |
| Accumulated other comprehensive income/loss | -801,000,000 | -579,000,000 | -711,000,000 | -690,000,000 |
| Other stockholders' equity | 0 | 0 | 4,269,000,000 | 0 |
| Total stockholders' equity | 4,659,000,000 | 4,574,000,000 | 4,322,000,000 | 4,333,000,000 |
| Total equity | 4,822,000,000 | 4,816,000,000 | 4,546,000,000 | 4,548,000,000 |
| Minority interest | 163,000,000 | 242,000,000 | 224,000,000 | 215,000,000 |
| Total liabilities and total equity | 13,952,000,000 | 14,249,000,000 | 14,558,000,000 | 14,741,000,000 |
| Total investments | 770,000,000 | 415,000,000 | 309,000,000 | 277,000,000 |
| Total debt | 4,862,000,000 | 5,368,000,000 | 5,563,000,000 | 5,875,000,000 |
| Net debt | 3,244,000,000 | 4,066,000,000 | 4,050,000,000 | 4,425,000,000 |
Akzo Nobel N.V. Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 915,000,000 | 668,000,000 | 1,120,000,000 | 254,000,000 |
| Cash from investing | 424,000,000 | -132,000,000 | -144,000,000 | -1,095,000,000 |
| Cash from financing | -964,000,000 | -684,000,000 | -827,000,000 | 1,141,000,000 |
| Net change in cash | 316,000,000 | -180,000,000 | 55,000,000 | 286,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 636,000,000 | 542,000,000 | 442,000,000 | 388,000,000 |
| Depreciation and amortization | 378,000,000 | 371,000,000 | 355,000,000 | 368,000,000 |
| Deferred income tax | 0 | 0 | -9,000,000 | -8,000,000 |
| Stock-based compensation | 0 | 0 | 0 | 16,000,000 |
| Change in working capital | 472,000,000 | -199,000,000 | -33,000,000 | -573,000,000 |
| Accounts receivable | 0 | 12,000,000 | -111,000,000 | -95,000,000 |
| Inventory | 0 | -83,000,000 | 131,000,000 | -134,000,000 |
| Accounts payable | 0 | -135,000,000 | 234,000,000 | -280,000,000 |
| Other working capital | 472,000,000 | 7,000,000 | -287,000,000 | -64,000,000 |
| Other non-cash items | -571,000,000 | -46,000,000 | 365,000,000 | 63,000,000 |
| Net cash from operating activities | 915,000,000 | 668,000,000 | 1,120,000,000 | 254,000,000 |
| Investments in property, plant and equipment | -309,000,000 | -306,000,000 | -286,000,000 | -292,000,000 |
| Acquisitions (net) | 799,000,000 | 2,000,000 | -18,000,000 | -552,000,000 |
| Purchases of investments | -314,000,000 | -320,000,000 | -64,000,000 | -1,361,000,000 |
| Sales/maturities of investments | 174,000,000 | 423,000,000 | 142,000,000 | 1,084,000,000 |
| Other investing activities | 74,000,000 | 69,000,000 | 82,000,000 | 26,000,000 |
| Net cash from investing activities | 424,000,000 | -132,000,000 | -144,000,000 | -1,095,000,000 |
| Net debt issuance | -582,000,000 | -295,000,000 | -459,000,000 | 2,189,000,000 |
| Long-term net debt issuance | -582,000,000 | -295,000,000 | -459,000,000 | 2,189,000,000 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | 0 | 0 | 0 | -669,000,000 |
| Net common stock issuance | 0 | 0 | 0 | -669,000,000 |
| Common stock issuance | 0 | 0 | 0 | 0 |
| Common stock repurchased | 0 | 0 | 0 | -669,000,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -339,000,000 | -385,000,000 | -343,000,000 | -350,000,000 |
| Common dividends paid | -339,000,000 | -385,000,000 | -343,000,000 | -350,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -43,000,000 | -4,000,000 | -25,000,000 | -29,000,000 |
| Net cash from financing activities | -964,000,000 | -684,000,000 | -827,000,000 | 1,141,000,000 |
| Effect of FX changes on cash | -59,000,000 | -32,000,000 | -94,000,000 | -14,000,000 |
| Net change in cash | 316,000,000 | -180,000,000 | 55,000,000 | 286,000,000 |
| Cash at end of period | 1,618,000,000 | 1,273,000,000 | 1,453,000,000 | 1,398,000,000 |
| Cash at beginning of period | 1,302,000,000 | 1,453,000,000 | 1,398,000,000 | 1,112,000,000 |
| Operating cash flow | 915,000,000 | 741,000,000 | 1,210,000,000 | 291,000,000 |
| Capital expenditure | -309,000,000 | -306,000,000 | -286,000,000 | -292,000,000 |
| Free cash flow | 606,000,000 | 362,000,000 | 834,000,000 | -29,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |